Literature DB >> 23317892

Expression and significance of VEGF and p53 in degenerate intervertebral disc tissue.

Xiao-Yu Lu1, Xiao-Hong Ding, Li-Jun Zhong, Hong Xia, Xiao-Dong Chen, Hai Huang.   

Abstract

OBJECTIVE: To investigate the mechanism of expression and significance of vascular endothelial growth factor (VEGF) and p53 in degenerate intervertebral disc tissue.
METHODS: Pathological sections collected from 156 patients with lumbar disc herniation after surgery were tested by immunohistochemistry method, for evaluation of the expression of VEGF and p53 in degenerate intervertebral disc tissue.
RESULTS: 98 cases (62.8%) with vascular infiltration phenomenon are found, and positive rates of VEGF and p53 in degenerate intervertebral disc tissue are 73.42% (116/156) and 58.97% (92/156); co-expression rate is 53.2%(83/156); the expression rates of VEFG and p53 are significantly higher in the tissue with blood vessel infiltration than in the tissue without infiltration; there is a close relationship of VEGF with p53.
CONCLUSIONS: VEGF and p53 gene synergetic express in degenerate intervertebral disc tissue, working together in neovascularization and infiltration, and accelerating intervertebral disc tissue degeneration.
Copyright © 2013 Hainan Medical College. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23317892     DOI: 10.1016/S1995-7645(12)60206-5

Source DB:  PubMed          Journal:  Asian Pac J Trop Med        ISSN: 1995-7645            Impact factor:   1.226


  8 in total

1.  Senotherapeutic drugs for human intervertebral disc degeneration and low back pain.

Authors:  Hosni Cherif; Daniel G Bisson; Matthew Mannarino; Oded Rabau; Jean A Ouellet; Lisbet Haglund
Journal:  Elife       Date:  2020-08-21       Impact factor: 8.140

2.  Differential expression of p38 MAPK α, β, γ, δ isoforms in nucleus pulposus modulates macrophage polarization in intervertebral disc degeneration.

Authors:  Chen Yang; Peng Cao; Yang Gao; Ming Wu; Yun Lin; Ye Tian; Wen Yuan
Journal:  Sci Rep       Date:  2016-02-25       Impact factor: 4.379

3.  Inhibiting Vascular Endothelial Growth Factor in Injured Intervertebral Discs Attenuates Pain-Related Neuropeptide Expression in Dorsal Root Ganglia in Rats.

Authors:  Jun Sato; Kazuhide Inage; Masayuki Miyagi; Yoshihiro Sakuma; Kazuyo Yamauchi; Masao Koda; Takeo Furuya; Junichi Nakamura; Miyako Suzuki; Go Kubota; Yasuhiro Oikawa; Takeshi Sainoh; Kazuki Fujimoto; Yasuhiro Shiga; Koki Abe; Hirohito Kanamoto; Masahiro Inoue; Hideyuki Kinoshita; Masaki Norimoto; Tomotaka Umimura; Kazuhisa Takahashi; Seiji Ohtori; Sumihisa Orita
Journal:  Asian Spine J       Date:  2017-08-07

4.  Vascular endothelial growth factor gene variations as a risk predictor in disc degeneration.

Authors:  Aline Amaro; Ana Beatriz Guerra; Matheus Pippa Defino; Luiz Angelo Vieira; Carla Peluso; Bianca Bianco; Luciano Miller Reis Rodrigues
Journal:  Einstein (Sao Paulo)       Date:  2017 Oct-Dec

5.  VEGF vascularization pathway in human intervertebral disc does not change during the disc degeneration process.

Authors:  Simona Capossela; Alessandro Bertolo; Kapila Gunasekera; Tobias Pötzel; Martin Baur; Jivko V Stoyanov
Journal:  BMC Res Notes       Date:  2018-05-22

6.  Constant compression decreases vascular bud and VEGFA expression in a rabbit vertebral endplate ex vivo culture model.

Authors:  Jia-Wen Zhan; Shang-Quan Wang; Min-Shan Feng; Xu Wei; Jie Yu; Xun-Lu Yin; Tao Han; Li-Guo Zhu
Journal:  PLoS One       Date:  2020-06-25       Impact factor: 3.240

7.  The potential role and trend of HIF‑1α in intervertebral disc degeneration: Friend or foe? (Review).

Authors:  Yongjin Li; Shen Liu; Dayu Pan; Baoshan Xu; Xuewu Xing; Hengxing Zhou; Bin Zhang; Suzhe Zhou; Guangzhi Ning; Shiqing Feng
Journal:  Mol Med Rep       Date:  2021-02-04       Impact factor: 2.952

8.  Treatment outcomes of injectable thermosensitive hydrogel containing bevacizumab in intervertebral disc degeneration.

Authors:  Qian Chen; Juehan Wang; Qinghong Xia; Lei Wu; Fei Chen; Li Li; Ce Zhu; Miaomiao He; Yulin Jiang; Yong Huang; Hong Ding; Ruibang Wu; Li Zhang; Yueming Song; Liming Liu
Journal:  Front Bioeng Biotechnol       Date:  2022-09-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.